98%
921
2 minutes
20
Genetic predisposition through single-nucleotide variation (SNV) influences circulatory soluble junctional adhesion molecule-A (sJAM-A) levels in coronary artery disease (CAD) patients. Homozygous carriers of the minor alleles (SNVs rs2774276, rs790056) show enhanced levels of thrombo-inflammatory sJAM-A. Both SNVs and sJAM-A are associated with worse prognosis for recurrent myocardial infarction in CAD patients. Platelet surface-associated JAM-A correlate with platelet activation markers in CAD patients. Activated platelets shed transmembrane-JAM-A, generating proinflammatory sJAM-A and JAM-A-bearing microparticles. Platelet transmembrane-JAM-A and sJAM-A as homophilic interaction partners exaggerate thrombotic and thrombo-inflammatory platelet monocyte interactions. Therapeutic strategies interfering with this homophilic interface may regulate thrombotic and thrombo-inflammatory platelet response in cardiovascular pathologies where circulatory sJAM-A levels are elevated.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156439 | PMC |
http://dx.doi.org/10.1016/j.jacbts.2022.03.003 | DOI Listing |
Arrhythm Electrophysiol Rev
August 2025
Department of Cardiology, National University Heart Centre Singapore Singapore.
Sudden cardiac death (SCD) is one of the leading causes of death worldwide. Coronary artery disease (CAD) is the predominant cause of SCD in older individuals, while inherited cardiomyopathies and channelopathies are more common in younger individuals under the age of 35 years. Genetic disorders associated with SCD have traditionally been perceived as monogenic disorders.
View Article and Find Full Text PDFJ Inflamm Res
August 2025
Department of Cardiology, Xuancheng People's Hospital, Xuancheng, Anhui, People's Republic of China.
Objective: To investigate the correlation between the serum homocysteine (HCY) to apolipoprotein A-1 (ApoA-1) ratio (HAR) and Coronary Artery Disease (CAD).
Methods: Patients who underwent coronary angiography due to chest pain at two medical centers were selected. Serum homocysteine (HCY), apolipoprotein A1 (ApoA-1), albumin, and other indicators were measured in each group, and the HAR was calculated for statistical analysis.
JRSM Cardiovasc Dis
September 2025
Division of Reproductive, Child Health and Nutrition, Indian Council of Medical Research, Department of Health Research, Ministry of Health and Family Welfare, Government of India, New Delhi, India.
Background: Statins are the most widely prescribed drugs for dyslipidemia and CAD. But evidence on their cognitive effects is conflicting. A unique genetic makeup and variable lipid patterns make South Asians more susceptible to statin adverse effects.
View Article and Find Full Text PDFInt J Cardiol Cardiovasc Risk Prev
December 2025
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Background: Patients with coronary artery disease (CAD) have increased risk of ischemic stroke (IS). Our aim was to screen for significant electrocardiogram (ECG) features for IS risk in patients treated for acute coronary syndrome (ACS).
Methods: This retrospective registry study is based on 7760 ACS patients treated in Tays Heart Hospital (2007-2018) with follow-up for incident IS until December 31st 2020.
Eur Heart J Cardiovasc Imaging
September 2025
Bosch Health Campus, Robert Bosch Hospital, Department of Cardiology and Angiology, Stuttgart, Germany.
Aims: For many years, visual assessment has been the mainstay of detecting obstructive coronary artery disease (CAD) by stress perfusion cardiovascular magnetic resonance (S-CMR). Recently, fully automated quantitative assessment of myocardial blood flow (MBF) has been introduced. The value of MBF quantification in patients with coronary chronic total occlusion (CTO) is unknown.
View Article and Find Full Text PDF